Terms: = Ovarian cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Diagnosis
27 results:
1. Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
Borella F; Bertero L; Valabrega G; Fucina S; Cassoni P; Benedetto C
Int J Gynaecol Obstet; 2024 Jan; 164(1):262-269. PubMed ID: 37496460
[TBL] [Abstract] [Full Text] [Related]
2. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
[TBL] [Abstract] [Full Text] [Related]
3. Health-related quality of life in children and adolescents with pleuropulmonary blastoma: A report from the International PPB/DICER1 Registry.
Nelson AT; Dybvik A; Mallinger P; Weiss McQuaid S; Watson D; Harney LA; Stewart DR; Dehner LP; Messinger YH; Kunin-Batson AS; Schultz KAP
Pediatr Blood Cancer; 2023 Apr; 70(4):e30077. PubMed ID: 36424733
[TBL] [Abstract] [Full Text] [Related]
4. Lack of impact of the aldh2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers.
Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
[TBL] [Abstract] [Full Text] [Related]
5. The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.
Klotz DM; Link T; Goeckenjan M; Wimberger P; Kuhlmann JD
Mol Oncol; 2021 Sep; 15(9):2491-2503. PubMed ID: 33690968
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic Discordance in Intraoperative Frozen Section diagnosis of ovarian Tumors: A Literature Review and Analysis of 871 Cases Treated at a Japanese cancer Center.
Yoshida H; Tanaka H; Tsukada T; Abeto N; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2021 Feb; 29(1):30-38. PubMed ID: 32955372
[TBL] [Abstract] [Full Text] [Related]
7. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer.
Frey MK; Ellis AE; Zeligs K; Chapman-Davis E; Thomas C; Christos PJ; Kolev V; Prasad-Hayes M; Cohen S; Holcomb K; Blank SV
Am J Obstet Gynecol; 2020 Nov; 223(5):725.e1-725.e9. PubMed ID: 32598911
[TBL] [Abstract] [Full Text] [Related]
8. Operative management of pediatric ovarian tumors and the challenge of fertility-preservation: Results from the UK CCLG Surgeons cancer Group Nationwide Study.
Braungart S; ; Craigie RJ; Farrelly P; Losty PD
J Pediatr Surg; 2020 Nov; 55(11):2425-2429. PubMed ID: 32234316
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
Chen Y; Ning Y; Zhang Q; Xie Y
Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
[TBL] [Abstract] [Full Text] [Related]
10. Secondary tumors of the GI tract: origin, histology, and endoscopic findings.
Gilg MM; Gröchenig HP; Schlemmer A; Eherer A; Högenauer C; Langner C
Gastrointest Endosc; 2018 Jul; 88(1):151-158.e1. PubMed ID: 29476848
[TBL] [Abstract] [Full Text] [Related]
11. Associations Between cancer Predisposition Testing Panel Genes and Breast cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract] [Full Text] [Related]
12. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract] [Full Text] [Related]
13. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.
Clarke BA; Witkowski L; Ton Nu TN; Shaw PA; Gilks CB; Huntsman D; Karnezis AN; Sebire N; Lamovec J; Roth LM; Stewart CJ; Hasselblatt M; Foulkes WD; McCluggage WG
Histopathology; 2016 Nov; 69(5):727-738. PubMed ID: 27100627
[TBL] [Abstract] [Full Text] [Related]
14. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast cancer.
Kim J; Turan V; Oktay K
J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
[TBL] [Abstract] [Full Text] [Related]
15. Outcomes following implementation of symptom triggered diagnostic testing for ovarian cancer.
Rai N; Nevin J; Downey G; Abedin P; Balogun M; Kehoe S; Sundar S
Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():64-9. PubMed ID: 25766669
[TBL] [Abstract] [Full Text] [Related]
16. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
Vecchione A; Belletti B; Lovat F; Volinia S; Chiappetta G; Giglio S; Sonego M; Cirombella R; Onesti EC; Pellegrini P; Califano D; Pignata S; Losito S; Canzonieri V; Sorio R; Alder H; Wernicke D; Stoppacciaro A; Baldassarre G; Croce CM
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9845-50. PubMed ID: 23697367
[TBL] [Abstract] [Full Text] [Related]
17. Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature.
Valentin L; Ameye L; Franchi D; Guerriero S; Jurkovic D; Savelli L; Fischerova D; Lissoni A; Van Holsbeke C; Fruscio R; Van Huffel S; Testa A; Timmerman D
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):80-9. PubMed ID: 23001924
[TBL] [Abstract] [Full Text] [Related]
18. Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
Zhang W; Yang HC; Wang Q; Yang ZJ; Chen H; Wang SM; Pan ZM; Tang BJ; Li QQ; Li L
Anticancer Res; 2011 Oct; 31(10):3423-8. PubMed ID: 21965756
[TBL] [Abstract] [Full Text] [Related]
19. The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients.
Barak F; Milgrom R; Laitman Y; Gemer O; Rabinovich A; Piura B; Anteby E; Baruch GB; Korach J; Friedman E
Gynecol Oncol; 2010 Dec; 119(3):511-5. PubMed ID: 20850175
[TBL] [Abstract] [Full Text] [Related]
20. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
[TBL] [Abstract] [Full Text] [Related]
[Next]
